Home » Topics » BioWorld Science

BioWorld Science
RSS

Amino acid derivative may be schizophrenia treatment

July 1, 2019

Addressing glioblastoma by targeting LDLR with VH-DO-33 radioisotopes

July 1, 2019

[18F]Afatinib PET/CT as promising new tool for selecting patients with NSCLC for afatinib therapy

July 1, 2019

Notch1 as a promising new therapeutic target in multiple myeloma

July 1, 2019

Phase II results presented for pazopanib in patients with progressive carcinoid tumors

July 1, 2019

MolMed suspends enrollment of new patients in phase III TK008 study of Zalmoxis

July 1, 2019

ImmusanT discontinues phase II study of Nexvax2 in celiac disease

July 1, 2019

Bayer initiates phase II AVANTI study of BAY-1753011 in congestive heart failure

July 1, 2019

AptaTargets initiates first-in-human trial of ApTOLL

July 1, 2019

BR-11257, a novel nonstabilizing soluble guanylyl cyclase partial agonist

July 1, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...